Beth O. Van Emburgh

DNA Methylation Inhibitor 5-Aza-2′-Deoxycytidine Induces Reversible Genome-Wide DNA Damage That Is Distinctly Influenced by DNA Methyltransferases 1 and 3B

Stela S. Palii, Beth O. Van Emburgh, Umesh T. Sankpal et al. · Molecular and Cellular Biology · 2007 · 380 citations · Full text

Medicine, Cancer Biology, Oncology +17

Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer

Beth O. Van Emburgh, Sabrina Arena, Giulia Siravegna et al. · Nature Communications · 2016 · 211 citations · Full text

Medicine, Oncology, Pharmacology +17

TGFα and Amphiregulin Paracrine Network Promotes Resistance to EGFR Blockade in Colorectal Cancer Cells

Sebastijan Hobor, Beth O. Van Emburgh, Emily Crowley et al. · Clinical Cancer Research · 2014 · 114 citations · Full text

Medicine, Oncology, Pharmacology +17

A Novel DNMT3B Splice Variant Expressed in Tumor and Pluripotent Cells Modulates Genomic DNA Methylation Patterns and Displays Altered DNA Binding

Suhasni Gopalakrishnan, Beth O. Van Emburgh, Jixiu Shan et al. · Molecular Cancer Research · 2009 · 98 citations · Full text

Medicine, Genetics, Molecular Biology +17

Modulation of Dnmt3b function in vitro by interactions with Dnmt3L, Dnmt3a and Dnmt3b splice variants

Beth O. Van Emburgh, Keith D. Robertson · Nucleic Acids Research · 2011 · 70 citations · Full text

Life Sciences, Genetics, Molecular Biology +14